141 related articles for article (PubMed ID: 31718365)
21. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
[TBL] [Abstract][Full Text] [Related]
22. Loss of BRG1 (
Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
[TBL] [Abstract][Full Text] [Related]
23. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
[TBL] [Abstract][Full Text] [Related]
24. INI1-deficient tumors: diagnostic features and molecular genetics.
Hollmann TJ; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
[TBL] [Abstract][Full Text] [Related]
25. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).
Kordes U; Bartelheim K; Modena P; Massimino M; Biassoni V; Reinhard H; Hasselblatt M; Schneppenheim R; Frühwald MC
Pediatr Blood Cancer; 2014 May; 61(5):919-21. PubMed ID: 24123847
[TBL] [Abstract][Full Text] [Related]
26. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility.
Kim HJ; Kim MH; Kwon J; Kim JY; Park K; Ro JY
Ann Diagn Pathol; 2012 Oct; 16(5):411-5. PubMed ID: 21724432
[TBL] [Abstract][Full Text] [Related]
27. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
[TBL] [Abstract][Full Text] [Related]
28. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
29. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1].
Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV
Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778
[TBL] [Abstract][Full Text] [Related]
30. Intracranial atypical teratoid/rhabdoid tumor presenting as an axillary mass: a case report and review of literature.
Bush JW; Hancock B; Israels SJ; Ellison DW; Stefanovici C; Krawitz S
Pediatr Dev Pathol; 2014; 17(2):122-5. PubMed ID: 24555876
[TBL] [Abstract][Full Text] [Related]
31. Biology and Treatment of Rhabdoid Tumor.
Geller JI; Roth JJ; Biegel JA
Crit Rev Oncog; 2015; 20(3-4):199-216. PubMed ID: 26349416
[TBL] [Abstract][Full Text] [Related]
32. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
33. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
[TBL] [Abstract][Full Text] [Related]
34. [Atypical teratoid/rhabdoid tumors of childhood].
Mitrofanova AM; Konovalov DM; Kisliakov AN; Roshchin VIu; Abramov DS
Arkh Patol; 2013; 75(5):36-42. PubMed ID: 24341231
[TBL] [Abstract][Full Text] [Related]
35. Aggressive uterine sarcoma with rhabdoid features: diagnosis by peritoneal fluid cytology and absence of INI1 gene mutation.
Knapik J; Yachnis AT; Ripley D; Biegel JA; Rathor S; Hardt NS; Talerman A; Wilkinson EJ
Hum Pathol; 2001 Aug; 32(8):884-6. PubMed ID: 11521235
[TBL] [Abstract][Full Text] [Related]
36. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors.
Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA
Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529
[TBL] [Abstract][Full Text] [Related]
37. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
[TBL] [Abstract][Full Text] [Related]
38. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
[TBL] [Abstract][Full Text] [Related]
39. INI1/SMARCB1-Deficient Carcinoma (Rhabdoid Tumor) of the Lacrimal Gland.
Srinivasan A; Tuluc M; Jordan AJ; Curry JM; Bilyk JR
Ophthalmic Plast Reconstr Surg; 2019; 35(2):e41-e43. PubMed ID: 30856630
[TBL] [Abstract][Full Text] [Related]
40. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
Agaimy A
Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]